European Archives - Page 506 of 1562 - European Medical Journal

Novel Oral Norovirus Vaccine Shows Strong Immune Response

A new orally administered norovirus vaccine tablet has demonstrated promising safety and immunogenicity in a clinical trial involving older adults.

Spending Time in Nature Lowers GI Symptoms in Young Children

A randomised controlled trial in Japan suggests that nature exposure in early childhood may reduce GI symptoms, lower stress levels, and enhance gut microbiota diversity.

Accuracy of Ultrasound Guided Percutaneous Splenic Biopsy

Splenic abnormalities usually present as a focal lesion(s) or diffuse splenomegaly outside the context of trauma. Most splenic lesions are…

Optimising Treatment Strategies for Advanced Melanoma

A new study investigates the combination of nivolumab and hypofractionated radiotherapy in advanced melanoma.

Current Treatment of Advanced Prostate Cancer: The Balance between Efficacy and Safety

Understanding the burden and measurement of pruritus in PBC

Primary biliary cholangitis (PBC) often causes pruritus, impacting QoL. Validated patient-reported outcomes (PROs), such as PBC-40 an WI-NRS, can assess severity and aid management…

EMJ Hepatology 13 [Supplement 1] 2025

In this latest review article, explore the most recent data presented at the 2024 American Association for the Study of Liver Diseases…

Parkinson’s Disease Cases Predicted to Double by 2050: Global Study

Parkinson’s disease cases are set to double by 2050 due to ageing populations. Study highlights urgent need for action.

Advancements in Laparoscopic Surgery for Early Prostate Cancer

Recent research comparing laparoscopic and open radical prostatectomy outcomes shows that radical prostatectomy leads to shorter hospital stays.

Dupilumab Reduces Airway Inflammation in Type 2 Asthma

A Phase IV trial has demonstrated that dupilumab significantly reduces airway inflammation in patients with uncontrolled, moderate-to-severe type 2 asthma.